HI SB2269

Requires Hawaii's Medicaid managed care and fee-for-service programs to provide prescription drug coverage for buprenorphine when used to treat opioid dependency.

Exempts buprenorphine prescriptions from copayment requirements and prior authorization requirements.

Defines buprenorphine as a Schedule III drug used in the treatment of opioid dependency.

Takes effect upon approval, contingent on approval of the Hawaii Medicaid state plan by the Centers for Medicare and Medicaid Services.